Ramelteon Tablet shortage
To Be Discontinued 2 presentations · 1 manufacturers · first FDA posting 2026-03-19 · last update 2026-03-19
Manufacturers: Takeda Pharmaceuticals USA Inc.
Stated reasons (per FDA): Not stated
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Rozerem, Tablet, 8 mg (NDC 64764-805-10) | Takeda Pharmaceuticals USA Inc. | To Be Discontinued | — | Product is expected to be available through February 2027. | Posted 03/19/2026 Updated 03/19/2026 Discontinued 03/19/2026 |
| Rozerem, Tablet, 8 mg (NDC 64764-805-30) | Takeda Pharmaceuticals USA Inc. | To Be Discontinued | — | Product is expected to be available through June 2027. | Posted 03/19/2026 Updated 03/19/2026 Discontinued 03/19/2026 |
Get the weekly shortage roundup: a free email of FDA shortage changes (open form)